Vivani Medical, Inc. (VANI) Earnings History
Annual and quarterly earnings data from 2012 to 2024
Loading earnings history...
VANI EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
VANI Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export VANI earnings history in CSV or JSON format
Free sign-in required to download data
Vivani Medical, Inc. (VANI) Earnings Overview
As of May 8, 2026, Vivani Medical, Inc. (VANI) reported trailing twelve-month net income of -$26M, reflecting +14.0% year-over-year growth. The company earned $-0.44 per diluted share over the past four quarters.
Looking at the long-term picture, VANI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$9M in fiscal 2020.
Vivani Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including GKOS (-$189M net income, -37.0% margin), BRNS (-$52M net income), NVCR (-$173M net income, -20.8% margin), VANI has comparable earnings metrics. Compare VANI vs GKOS →
VANI Earnings vs Peers
Earnings metrics vs comparable public companies
VANI Historical Earnings Data (2012–2024)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$23M | +8.4% | -$25M | $-0.43 | - | - |
| 2023 | -$26M | -84.7% | -$27M | $-0.50 | - | - |
| 2022 | -$14M | -8.7% | -$21M | $-0.17 | - | - |
| 2021 | -$13M | -37.7% | -$13M | $-0.33 | - | - |
| 2020 | -$9M | +72.4% | -$9M | $-0.33 | - | - |
| 2019 | -$34M | +4.3% | -$31M | $-2.15 | -994.1% | -905.5% |
| 2018 | -$35M | -23.1% | -$35M | $-4.08 | -508.9% | -505.0% |
| 2017 | -$29M | +14.1% | -$29M | $-4.01 | -358.1% | -360.5% |
| 2016 | -$33M | -65.7% | -$33M | $-5.99 | -832.6% | -833.4% |
| 2015 | -$20M | +43.1% | -$20M | $-4.09 | -223.7% | -224.0% |
See VANI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VANI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VANI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVANI — Frequently Asked Questions
Quick answers to the most common questions about buying VANI stock.
Is VANI growing earnings?
VANI EPS stands at $-0.44, with +14.0% growth matching the 5-year CAGR of N/A. TTM net income is $-26M. Earnings trajectory remains consistent.
What are VANI's profit margins?
Vivani Medical, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are VANI's earnings?
VANI earnings data spans 2012-2024. The current earnings trend is +14.0% YoY. Historical data enables comparison across business cycles.